A NEW STREPTOMYCIN GROUP ANTIBIOTIC PRODUCED BY STREPTOMYCES SIOYAENSIS
Sir:
A new antibiotic, 6"'-O-a-n-mannopyranosyl mannosidostreptomycin has been isolated from the culture filtrate of strain MD753-C2, together with streptomycin and mannosidostreptomycin. This strain has been classified as Streptomyces sioyaensis1) which is a new streptomycin-producer. In this communication, the isolation, characterization and structural elucidation of the antibiotic are reported.
S. sioyaensis MD753-C2 on an asparagineglucose agar slant was inoculated into a medium (110 ml) containing starch 2.0 %, glucose 0.05 %, soybean meal 2.5 %, Peptone 0.1 %, NaCl 0.3 %, CaCl2 0.1 %, K2HPO4 0.1 % and MgSO4 • 7H2O 0.05 % (pH 6.2) in a 500-m1 baffled Erlenmeyer flask and cultured for 3 days at 37°C on a rotatory shaker (180 rpm). The culture broth in 37 flasks was collected and filtered at pH 6.4 to give 3.2 liters of the filtrate (22 ug/ml assayed by the cylinder plate method using Bacillus subtilis PCI219 as the test organism and the pure new antibiotic hydrochloride, 890 iLg/mg, as the assay standard). Siomycin produced by S. sioyaensis1) and its related peptide antibiotics could not be found in the filtrate.
The antibiotics in the filtrate were adsorbed on a column of Amberlite IRC-50 (Na+ : H+, 7: 3, 240 ml) and eluted with 1 N HCL The active eluate (226 ml) was neutralized to pH 5.6 with Amberlite IR-45 (OH-) and chromatographed on a carbon column (4 g) eluted with 0.1 N HCI -MeOH (1: 1). After neutralization with Amberlite IR-45 (OH-), the active eluate (65 ml) was concentrated to give a crude powder (214 mg, 246 ,ug/mg). The high-voltage paper electrophoresis2) (HCOOH -CH3COOH -H2O, 1: 3: 36; 3,500 V; detected by bioautography using B. subtilis PCI219; Rm was calculated taking the mobility of alanine as 1.0) showed that the crude powder contained a new antibiotic (Rm 1.02), mannosidostreptomycin (Rm 1.19) and a small amout of streptomycin (Rm 1.33). Separation of the individual antibiotics was achieved by column chromatography on CM-Sephadex C-25 (25 ml, equilibrated with 0.4 M NaCl) developed with 0.4 M NaCl (90 ml) and 0.6 M NaCl (350 ml). Approximately 5-ml fractions were collected. The new antibiotic was eluted in fractions 27~35 (45 ml) and mannosidostreptomycin in fractions 36~40 (25 ml). The antibiotic in the former eluate was further purified by carbon chromatography (500 mg) eluted with 0.1 N HCl-MeOH (1: 1) followed by column chromatography on Sephadex LH-20 (100 ml) developed with MeOH to give a pure antibiotic hydrochloride (17 mg, 890 ttg/mg) as a colorless hygroscopic powder. Mannosidostreptomycin in the latter eluate was purified by carbon chromatography (300 mg) eluted with Scheme 1. Table 1 ), the structure of the new antibiotic was suggested to be 6"-or 6"'-O-a-D-mannopyranosyl mannosidostreptomycin.
In order to determine the position of the glycosidic linkage of the mannosidostreptomycin molecule with mannose, the antibiotic was modified as follows. After reduction of the antibiotic with PtO2 in H2O overnight in a Parr apparatus (2.8 kg/cm2), N-benzyloxycarbonylation with benzyloxycarbonyl chloride in the presence of Na2CO3 in a mixture of acetone and H2O (1: 2) at pH 9.4, followed by acetalation with p-tolualdehyde dimethyl acetal and camphorsulfonic The hydrochlorides of antibiotics were measured.
Chemical shifts of streptomycin were assigned according to ref 3. Assignments * within any vertical column may be reversed. While, the similar modifications of streptomycin and mannosidostreptomycin gave 2"-N-(benzyloxycarbonyl)dihydro-bis(O-p-methylbenzylidene) (SI-MS: m/z 922, MH+) and -tris(O p-methylbenzylidene) (SI-MS: m/z 1,187, MH+) derivatives, respectively. From these results, the structure of the antibiotic was determined to be 6"'-O-a-D-mannopyranosyl mannosidostreptomycin.
The antibiotic has weak antibacterial activity as shown in 
